-
Alpha Tau Announces FDA Approval of IDE to Initiate Multi-Center Investigator-Initiated Study of Alpha DaRT in Immunocompromised Patients with Recurrent cSCC | Morningstar
Source: Buzz FX / 20 Sep 2024 09:07:16 America/Chicago
[GlobeNewswire](/news/globe-newswire) Alpha Tau Announces FDA Approval of IDE to Initiate Multi-Center Investigator-Initiated Study of Alpha DaRT in Immunocompromised Patients with Recurrent cSCC JERUSALEM, Sept.
Read more...